{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:03:58Z","timestamp":1790737438331,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00513-y","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:07:09Z","timestamp":1748250429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between hepatitis C virus infection and rheumatoid arthritis: a nationwide cross-sectional study"],"prefix":"10.1186","volume":"9","author":[{"given":"Lin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"1","key":"513_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10\u20138.","journal-title":"Nat Immunol"},{"issue":"3","key":"513_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.semarthrit.2017.04.004","volume":"47","author":"ED Ferucci","year":"2017","unstructured":"Ferucci ED, Choromanski TL, Varney DT, Ryan HS, Townshend-Bulson LJ, McMahon BJ, Wener MH. Prevalence and correlates of hepatitis C virus-associated inflammatory arthritis in a population-based cohort. Semin Arthritis Rheum. 2017;47(3):445\u201350.","journal-title":"Semin Arthritis Rheum"},{"issue":"24","key":"513_CR3","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMp2031110","volume":"383","author":"JH Hoofnagle","year":"2020","unstructured":"Hoofnagle JH, Feinstone SM. The discovery of hepatitis C - The 2020 nobel prize in physiology or medicine. N Engl J Med. 2020;383(24):2297\u20139.","journal-title":"N Engl J Med"},{"issue":"1 Suppl 48","key":"513_CR4","first-page":"S39","volume":"26","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, Menegatti E, Olivieri I, Puoti M, Palazzi C, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S39\u201347.","journal-title":"Clin Exp Rheumatol"},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"102255","DOI":"10.1016\/j.tmaid.2022.102255","volume":"46","author":"N Salari","year":"2022","unstructured":"Salari N, Kazeminia M, Hemati N, Ammari-Allahyari M, Mohammadi M, Shohaimi S. Global prevalence of hepatitis C in general population: A systematic review and meta-analysis. Travel Med Infect Dis. 2022;46:102255.","journal-title":"Travel Med Infect Dis"},{"issue":"11","key":"513_CR6","doi-asserted-by":"publisher","first-page":"e113579","DOI":"10.1371\/journal.pone.0113579","volume":"9","author":"FH Su","year":"2014","unstructured":"Su FH, Wu CS, Sung FC, Chang SN, Su CT, Shieh YH, Yeh CC. Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in Taiwan. PLoS ONE. 2014;9(11):e113579.","journal-title":"PLoS ONE"},{"issue":"7","key":"513_CR7","doi-asserted-by":"publisher","first-page":"e021747","DOI":"10.1136\/bmjopen-2018-021747","volume":"8","author":"CH Tung","year":"2018","unstructured":"Tung CH, Lai NS, Li CY, Tsai SJ, Chen YC, Chen YC. Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese National claims database. BMJ Open. 2018;8(7):e021747.","journal-title":"BMJ Open"},{"issue":"8","key":"513_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","volume":"46","author":"D Saadoun","year":"2007","unstructured":"Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford). 2007;46(8):1234\u201342.","journal-title":"Rheumatology (Oxford)"},{"key":"513_CR9","doi-asserted-by":"crossref","unstructured":"Akinbami LJ, Chen TC, Davy O, Ogden CL, Fink S, Clark J, Riddles MK, Mohadjer LK. National health and nutrition examination survey, 2017-March 2020 prepandemic file: sample design, estimation, and analytic guidelines. Vital Health Stat 1 2022(190):1\u201336.","DOI":"10.15620\/cdc:115434"},{"issue":"1","key":"513_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s41927-024-00447-x","volume":"8","author":"G Ma","year":"2024","unstructured":"Ma G, Zhang S, Luo Y, Zhang C, Xu W, Wang L. The association between composite dietary antioxidant index and rheumatoid arthritis: evidence from NHANES 2001\u20132020. BMC Rheumatol. 2024;8(1):74.","journal-title":"BMC Rheumatol"},{"issue":"1","key":"513_CR11","doi-asserted-by":"publisher","first-page":"21518","DOI":"10.1038\/s41598-023-49046-9","volume":"13","author":"SH Kim","year":"2023","unstructured":"Kim SH, Park SH, Lee H. Machine learning for predicting hepatitis B or C virus infection in diabetic patients. Sci Rep. 2023;13(1):21518.","journal-title":"Sci Rep"},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"1216445","DOI":"10.3389\/fnut.2023.1242115","volume":"10","author":"X Qi","year":"2023","unstructured":"Qi X, Li Y, Fang C, Jia Y, Chen M, Chen X, Jia J. The associations between dietary fibers intake and systemic immune and inflammatory biomarkers, a multi-cycle study of NHANES 2015\u20132020. Front Nutr. 2023;10:1216445.","journal-title":"Front Nutr"},{"issue":"4","key":"513_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2468-1253(23)00408-9","volume":"9","author":"K Heath","year":"2024","unstructured":"Heath K, Hill A. WHO hepatitis C elimination targets: the global equity challenge. Lancet Gastroenterol Hepatol. 2024;9(4):286\u20138.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"513_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jare.2016.07.005","volume":"8","author":"P Cacoub","year":"2017","unstructured":"Cacoub P, Comarmond C. New insights into HCV-related rheumatologic disorders: A review. J Adv Res. 2017;8(2):89\u201397.","journal-title":"J Adv Res"},{"key":"513_CR15","doi-asserted-by":"crossref","unstructured":"Napodano C, Ciasca G, Chiusolo P, Pocino K, Gragnani L, Stefanile A, Gulli F, Lorini S, Minnella G, Fosso F et al. Serological and molecular characterization of hepatitis C Virus-Related cryoglobulinemic vasculitis in patients without cryoprecipitate. Int J Mol Sci 2023;24(14).","DOI":"10.3390\/ijms241411602"},{"issue":"5","key":"513_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2019.06.029","volume":"71","author":"C Comarmond","year":"2019","unstructured":"Comarmond C, Lorin V, Marques C, Maciejewski-Duval A, Joher N, Planchais C, Touzot M, Biard L, Hieu T, Quiniou V, et al. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses. J Hepatol. 2019;71(5):908\u201319.","journal-title":"J Hepatol"},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"750753","DOI":"10.3389\/fimmu.2021.750753","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, Zhang L. B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol. 2021;12:750753.","journal-title":"Front Immunol"},{"issue":"3","key":"513_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00296-022-05169-2","volume":"43","author":"E Capkin","year":"2023","unstructured":"Capkin E, Yazici A, Karkucak M, Durmaz Y, Toprak M, Ataman S, Sahin N, Cuzdan N, Kasapoglu Aksoy M, Onder ME, et al. Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study. Rheumatol Int. 2023;43(3):523\u201331.","journal-title":"Rheumatol Int"},{"issue":"6","key":"513_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.5009\/gnl16434","volume":"11","author":"HL Lee","year":"2017","unstructured":"Lee HL, Bae SH, Jang B, Hwang S, Yang H, Nam HC, Sung PS, Lee SW, Jang JW, Choi JY, et al. Reactivation of hepatitis C virus and its clinical outcomes in patients treated with systemic chemotherapy or immunosuppressive therapy. Gut Liver. 2017;11(6):870\u20137.","journal-title":"Gut Liver"},{"issue":"2","key":"513_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/1744666X.2019.1705785","volume":"16","author":"YM Chiu","year":"2020","unstructured":"Chiu YM, Chen DY. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Rev Clin Immunol. 2020;16(2):207\u201328.","journal-title":"Expert Rev Clin Immunol"},{"issue":"Suppl 3","key":"513_CR21","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1093\/cid\/ciad344","volume":"77","author":"M Martinello","year":"2023","unstructured":"Martinello M, Naggie S, Rockstroh JK, Matthews GV. Direct-Acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: A narrative review. Clin Infect Dis. 2023;77(Suppl 3):S238\u201344.","journal-title":"Clin Infect Dis"},{"key":"513_CR22","doi-asserted-by":"crossref","unstructured":"Minosse C, Gruber CEM, Rueca M, Taibi C, Zaccarelli M, Grilli E, Montalbano M, Capobianchi MR, Antinori A, D\u2019Offizi G et al. Late relapse and reinfection in HCV patients treated with Direct-Acting antiviral (DAA) drugs. Viruses. 2021;13(6).","DOI":"10.3390\/v13061151"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00513-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:07:12Z","timestamp":1748250432000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00513-y","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the NCHS Ethics Review Board, and all participants provided written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}